C9458 — Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
C9458 is a HCPCS Level II code for florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries. It belongs to the Outpatient Prospective Payment System section. It was terminated on June 30, 2016 and is not valid on new claims.
This code has been terminated
CMS terminated C9458 on June 30, 2016. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for C9458
- Long descriptor
- Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
- Short descriptor
- Florbetaben f18
- Added
- January 1, 2016
- Terminated
- June 30, 2016
- BETOS
- O1E
- Pricing indicator
- 53 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Statute.
Codes adjacent to C9458
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If C9458 is not quite right, the correct code is very often within a few positions of it.
- C9450Injection, fluocinolone acetonide intravitreal implant, 0.01 mgterminated
- C9451Injection, peramivir, 1 mgterminated
- C9452Injection, ceftolozane 50 mg and tazobactam 25 mgterminated
- C9453Injection, nivolumab, 1 mgterminated
- C9454Injection, pasireotide long acting, 1 mgterminated
- C9455Injection, siltuximab, 10 mgterminated
- C9456Injection, isavuconazonium sulfate, 1 mgterminated
- C9457Injection, sulfur hexafluoride lipid microsphere, per mlterminated
- C9459Flutemetamol f18, diagnostic, per study dose, up to 5 millicuriesterminated
- C9460Injection, cangrelor, 1 mg
- C9461Choline c 11, diagnostic, per study doseterminated
- C9462Injection, delafloxacin, 1 mg
- C9463Injection, aprepitant, 1 mgterminated
- C9464Injection, rolapitant, 0.5 mgterminated
- C9465Hyaluronan or derivative, durolane, for intra-articular injection, per doseterminated
- C9466Injection, benralizumab, 1 mgterminated
Questions about C9458
What is HCPCS code C9458?
C9458 is a HCPCS Level II code for florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries. It sits in the Outpatient Prospective Payment System section.
Does Medicare cover C9458?
The CMS HCPCS file marks C9458 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is C9458 still valid?
No. C9458 was terminated on June 30, 2016 and should not be used on new claims.